KRAS and pachyonychia congenita: A recent study has shown that PC in older patients (>50 years) were significantly more likely to harbor genomic alterations in KRAS and SMAD4, whereas BRCA1 and BRCA2 alterations were more commonly detected in PC from younger patients (<50 years).